RESEARCH PAPER
Interaction of tiagabine with clonazepam in the mouse pentylenetetrazole-induced seizure model: a type I isobolographic analysis for parallel log-probit dose-response relationship lines
 
More details
Hide details
1
Department of Pathophysiology, Medical University, Lublin, Poland
2
Department of Physiopathology, Institute of Agricultural Medicine, Lublin, Poland
3
Department of Experimental and Clinical Pharmacology, Medical University, Lublin, Poland
CORRESPONDING AUTHOR
Jarogniew J. Łuszczki   

Department of Pathophysiology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland.
 
J Pre Clin Clin Res. 2008;2(2):141–146
KEYWORDS
ABSTRACT
Isobolographic analysis was used to characterize the interaction between tiagabine (TGB) and clonazepam (CZP) against pentylenetetrazole (PTZ)-induced clonic seizures in mice. The anticonvulsant effects of TGB in combination with CZP at 3 fi xed-ratios of 1:3, 1:1 and 3:1, were evaluated in the PTZ test in mice using type I isobolographic analysis for parallel dose-response relationship lines. Acute adverse-effect profiles for the combinations were determined by use of the step-through passive avoidance task (long-term memory), grip-strength (muscular strength), and chimney (motor coordination) tests. All combinations of TGB with CZP (at fixed-ratios 1:3, 1:1 and 3:1) were additive in terms of clonic seizure suppression in the PTZ test. Additionally, none of the examined combinations of TGB with CZP (at their median effective doses from the PTZ test) affected long-term memory, muscular strength and motor coordination in mice. Based on the isobolographic analysis of interaction, the combinations of TGB with CZP at the fixed-ratios 1:3, 1:1 and 3:1 displayed additivity in terms of suppression of PTZ-induced seizures and appear to be neutral combinations from a clinical viewpoint.
 
REFERENCES (39)
1.
Kwan P, Brodie MJ: Early identifi cation of refractory epilepsy. New Eng J Med 2000, 342, 314-319.
 
2.
Kwan P, Brodie MJ: Epilepsy after the fi rst drug fails: substitution or add-on? Seizure 2000, 9, 464-468.
 
3.
Stephen LJ, Brodie MJ: Seizure-freedom with more than one antiepileptic drug. Seizure 2002, 11, 349-351.
 
4.
Patsalos PN, Froscher W, Pisani F, van Rijn CM: The importance of drug interactions in epilepsy therapy. Epilepsia 2002, 43, 365-385.
 
5.
Patsalos PN, Perucca E: Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2003, 2, 347-356.
 
6.
Loscher W, Wauquier A: Use of animal models in developing guiding principles for polypharmacy in epilepsy. Epilepsy Res 1996, Suppl. 11, 61-65.
 
7.
Tallarida RJ: Drug synergism and dose-eff ect data analysis. Chapman & Hall/CRC, Boca Raton, 2000.
 
8.
Brodie MJ, Schachter SC: Fast Facts. Epilepsy (2nd ed.). Health Press, Oxford 2001.
 
9.
Czuczwar SJ, Patsalos PN: The new generation of GABA enhancers. Potential in the treatment of epilepsy. CNS Drugs 2001, 15, 339-350.
 
10.
Loscher W, Honack D, Fassbender CP, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res 1991, 8, 171-189.
 
11.
Łuszczki JJ, Świąder M, Parada-Turska J, Czuczwar SJ: Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice. Neuropsychopharmacology 2003, 28, 1817- 1830.
 
12.
Łuszczki JJ, Wojcik-Ćwikła J, Andres MM, Czuczwar SJ: Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Neuropsychopharmacology 2005, 30, 958-973.
 
13.
Litchfi eld JT, Wilcoxon F: A simplifi ed method of evaluating dose-eff ect experiments. J Pharmacol Exp Ther 1949, 96, 99-113.
 
14.
Łuszczki JJ, Czuczwar SJ: Isobolographic profi le of interactions between tiagabine and gabapentin: a preclinical study. Naunyn-Schmiedebergs Arch Pharmacol 2004, 369, 434-446.
 
15.
Łuszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ: Pharmacodynamic and/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole- induced seizures in mice: an isobolographic analysis. Epilepsy Behav 2005, 7, 639-651.
 
16.
Łuszczki JJ: Isobolographic analysis of interaction between oxcarbazepine and valproate in pentylenetetrazole-induced seizures in mice. JPCCR 2008, 2, 40-45.
 
17.
Łuszczki JJ, Czuczwar SJ: Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics - a comparative study. Epilepsy Res 2003, 56, 27-42.
 
18.
Łuszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ: Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Naunyn-Schmiedebergs Arch Pharmacol 2006, 373, 169-181.
 
19.
Łuszczki JJ, Borowicz KK, Swiader M, Czuczwar SJ: Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia 2003, 44, 489-499.
 
20.
Porreca F, Jiang Q, Tallarida RJ: Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction. Eur J Pharmacol 1990, 179, 463-468.
 
21.
Loewe S: The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 1953, 3, 285-290.
 
22.
Berenbaum MC: What is synergy? Pharmacol Rev, 1989, 41, 93-141. Erratum in: Pharmacol Rev 1990, 41, 422.
 
23.
Boissier JR, Tardy J, Diverres JC: Une nouvelle methode simple pour explorer l’action tranquilisante: le test de la cheminee. Med Exp (Basle) 1960, 3, 81-84.
 
24.
Łuszczki JJ, Czuczwar SJ: Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31, 529- 538.
 
25.
Łuszczki JJ, Zadrożniak A, Wlaź A, Andres-Mach M, Dudra-Jastrzębska M, Zwoliński J, Misiuta-Krzesińska M, Sielski M: Characterization of acute adverse-eff ect profi le of carbamazepine and valproate in the grip-strength test in mice. JPCCR 2008, 2, 46-48.
 
26.
Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J: Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks. Nature 1986, 321, 864- 866.
 
27.
Tallarida RJ: Interactions between drugs and occupied receptors. Pharmacol Ther, 2007, 113, 197-209.
 
28.
Łuszczki JJ: Isobolographic analysis of interaction between drugs with nonparallel dose-response relationship curves: a practical application. Naunyn-Schmiedebergs Arch Pharmacol 2007, 375, 105-114.
 
29.
Greco WR, Bravo G, Parsons JC: The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 1995, 47, 331-385.
 
30.
Łuszczki JJ, Czuczwar SJ: Isobolographic characterisation of interactions among selected newer antiepileptic drugs in the mouse pentylenetetrazole induced seizure model. Naunyn Schmiedebergs Arch Pharmacol 2005, 372, 41-54.
 
31.
Łuszczki JJ, Świąder M, Czuczwar M, Kiś J, Czuczwar SJ: Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. Pharmacol Biochem Behav 2003, 75, 319-327.
 
32.
Borowicz KK, Łuszczki JJ, Czuczwar SJ: Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice. Epilepsia 2004, 45, 1176-1183.
 
33.
Łuszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ: Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profi les of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis. Epilepsia 2006, 47, 1841-1854.
 
34.
Łuszczki JJ, Czuczwar SJ: Three-dimensional isobolographic analysis of interactions between lamotrigine and clonazepam in maximal electroshock induced seizures in mice. Naunyn Schmiedebergs Arch Pharmacol 2004, 370, 369-380.
 
35.
Haefely W: Benzodiazepines: mechanisms of action. In: Levy R, Mattson M, Meldrum BS, eds. Antiepileptic drugs. (3rd ed.). Raven Press, New York 1989, 721-734.
 
36.
Kellinghaus C, Dziewas R, Ludemann P: Tiagabine-related nonconvulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure, 2002, 11, 243-249.
 
37.
Genton P: When antiepileptic drugs aggravate epilepsy. Brain Dev 2000, 22, 75-80.
 
38.
Perucca E, Gram L, Avanzini G, Dulac O: Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998, 39, 5-17.
 
39.
Thomas P, Valton L, Genton P: Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 2006, 129, 1281-1292.
 
eISSN:1898-7516
ISSN:1898-2395